Capcom is firing on all cylinders in 2026 with two major releases driving exceptional financial results. Resident Evil Requiem, the ninth numbered entry in the horror franchise, has become a runaway success. The game sold over 1 million copies last quarter alone, pushing lifetime sales past 8 million units since its February launch. That performance makes Requiem one of the strongest entries in the franchise's storied history.
The article doesn't specify the second marquee release, but Capcom's earnings call confirms the company is leaning on both legacy franchises and new IP to sustain momentum through the year. This strategy reflects how the publisher has evolved beyond its core horror tentpoles. Resident Evil Requiem's strong sales indicate the franchise still has immense appeal despite being nearly four decades old. Players continue to show up for mainline entries when the quality justifies the entry fee.
For Capcom, this performance validates its approach to balancing blockbuster franchises with creative risks. The publisher has spent years rebuilding trust in Resident Evil after the franchise stumbled through several missteps in the 2010s. Resident Evil 7 and the Resident Evil 2 remake reset player expectations, and Resident Evil Village reinforced that momentum. Requiem builds on that foundation with strong critical reception and sustained commercial appeal.
The 8 million copy threshold matters for context. It places Requiem among the franchise's best sellers and demonstrates that horror games remain bankable when executed properly. In an industry obsessed with live-service and multiplayer experiences, a single-player horror game shipping 8 million copies sends a message about player hunger for focused, narrative-driven experiences.
With half the year complete, Capcom's performance suggests annual earnings will exceed expectations. The company benefits from having staggered its major releases and appears positioned for a strong finish